BENRALIZUMAB
benralizumab 30 mg/mL injection, 1 mL pen device
BENRALIZUMAB (11999M)
11999M
Manner of administration:Injection
Restriction
Indication: Uncontrolled severe asthma
Treatment phase: Balance of supply
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $3,194.33 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Fasenra Pen | |||||